Brief: Keros Therapeutics Announces Update On Enrollment In The Phase 2 TROPOS Trial
03/09/2024 13:40
Sept 3 (Reuters) - Keros Therapeutics Inc KROS.O :
* KEROS THERAPEUTICS ANNOUNCES UPDATE ON ENROLLMENT IN THE
PHASE 2
TROPOS TRIAL
* KEROS THERAPEUTICS INC - CLOSES SCREENING FOR TROPOS TRIAL
* KEROS THERAPEUTICS INC - TO PRESENT TOPLINE DATA IN Q2
2025
Source text for Eikon: ID:nGNX9Q27XX
Further company coverage: KROS.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Keros Therapeutics
See all newsBrief: Keros Therapeutics May Offer Up To $350 Million Of Securities - SEC Filing
Keros Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Keros Therapeutics Q2 net loss narrows on lower expenses
Brief: Keros Therapeutics - Keith Regnante Resigns As CFO
Keros Therapeutics posts Q1 net loss as license revenue drops